« FDA Strengthens Safety Information for Erythropoiesis-Stimulating Agents (ESAs) FDA today | Main | QuadTech's Sentinal System Shows Commitment to Manufacturers of Medical Devices »

FDA Approvals - New Phase IV Clinical Study Indicates LidoSite(R) Provides Rheumatology Patients


New Phase IV Clinical Study Indicates LidoSite(R) Provides Rheumatology Patients Superior Pain Relief (RedNova)
Vyteris Holdings (Nevada), Inc. (OTCBB: VYHN),

Acusphere, Inc. Reports 2006 Financial Results and Operating Highlights (RedNova)
Acusphere, Inc. (NASDAQ: ACUS) today reported financial results for the quarter and year ended December 31, 2006 and commented on operating progress. Financial Results The Company's financial results for the periods are summarized in the accompanying table.
 

©2006 FDA-News.com. All rights reserved.